dupilumab
regeneron,sanofi
['dupixent', 'dupilumab', '$regn']
$regn -dupixent (dupilumab) late-breaking phase 3 data at the eadv 2022 congress showed significant improvements in signs and symptoms of prurigo nodularis
My posts are my own.  Please do not use them for your investments, and please no disrespect!